Literature DB >> 26614034

Current Clinical Applications of Testicular Cancer Biomarkers.

Maria C Mir1, Nicola Pavan2, Mark L Gonzalgo3.   

Abstract

Current use of testicular biomarkers for screening, diagnosis, and follow-up is reviewed in the context of potential clinical utility of these tests. This information will be of value to clinicians to determine patient suitability for certain treatments and will also assist in reviewing current literature regarding potential biomarkers that may be used for testicular cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Markers; Mitochondrial DNA; Serum; Testicular germ cell tumors; Tumor markers; microRNAs

Mesh：

Substances：

Year:  2016        PMID： 26614034     DOI： 10.1016/j.ucl.2015.08.011

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  9 in total

Review 1.  Current management and management controversies in early- and intermediate-stage of nonseminoma germ cell tumors.

Authors:  Salim K Cheriyan; Marilin Nicholson; Ahmet M Aydin; Mounsif Azizi; Charles C Peyton; Wade J Sexton; Scott M Gilbert
Journal:  Transl Androl Urol       Date:  2020-01

2.  Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series.

Authors:  Petra Anheuser; Arlo Radtke; Christian Wülfing; Jennifer Kranz; Gazanfer Belge; Klaus-Peter Dieckmann
Journal:  Urol Int       Date:  2017-06-07       Impact factor: 2.089

Review 3.  Will Testicular Germ Cell Tumors Remain Untargetable?

Authors:  Fouad Aoun; Hampig Raphael Kourie; Simone Albisinni; Thierry Roumeguère
Journal:  Target Oncol       Date:  2016-12       Impact factor: 4.493

4.  Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.

Authors:  Takuma Narita; Shingo Hatakeyama; Tohru Yoneyama; Shintaro Narita; Shinichi Yamashita; Koji Mitsuzuka; Toshihiko Sakurai; Sadafumi Kawamura; Tatsuo Tochigi; Ippei Takahashi; Shigeyuki Nakaji; Yuki Tobisawa; Hayato Yamamoto; Takuya Koie; Norihiko Tsuchiya; Tomonori Habuchi; Yoichi Arai; Chikara Ohyama
Journal:  Cancer Med       Date:  2017-03-20       Impact factor: 4.452

5.  m6A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance.

Authors:  João Lobo; Ana Laura Costa; Mariana Cantante; Rita Guimarães; Paula Lopes; Luís Antunes; Isaac Braga; Jorge Oliveira; Mattia Pelizzola; Rui Henrique; Carmen Jerónimo
Journal:  J Transl Med       Date:  2019-03-12       Impact factor: 5.531

6.  Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.

Authors:  Klaus-Peter Dieckmann; Arlo Radtke; Lajos Geczi; Cord Matthies; Petra Anheuser; Ulrike Eckardt; Jörg Sommer; Friedemann Zengerling; Emanuela Trenti; Renate Pichler; Hanjo Belz; Stefan Zastrow; Alexander Winter; Sebastian Melchior; Johannes Hammel; Jennifer Kranz; Marius Bolten; Susanne Krege; Björn Haben; Wolfgang Loidl; Christian Guido Ruf; Julia Heinzelbecker; Axel Heidenreich; Jann Frederik Cremers; Christoph Oing; Thomas Hermanns; Christian Daniel Fankhauser; Silke Gillessen; Hermann Reichegger; Richard Cathomas; Martin Pichler; Marcus Hentrich; Klaus Eredics; Anja Lorch; Christian Wülfing; Sven Peine; Werner Wosniok; Carsten Bokemeyer; Gazanfer Belge
Journal:  J Clin Oncol       Date:  2019-03-15       Impact factor: 44.544

7.  Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.

Authors:  Klaus-Peter Dieckmann; Hanna Simonsen-Richter; Magdalena Kulejewski; Petra Anheuser; Henrik Zecha; Hendrik Isbarn; Uwe Pichlmeier
Journal:  Biomed Res Int       Date:  2019-05-28       Impact factor: 3.411

8.  Hyperandrogenism and Hyperestrogenism Secondary to Mixed Germ-Cell Testicular Tumor.

Authors:  Daniel I Sanford; Kian Asanad; Nima Nassiri; Jamal Nabhani
Journal:  Cureus       Date:  2022-07-28

Review 9.  Current Standards and Recent Advances in Biomarkers of Major Endocrine Tumors.

Authors:  Yanhong Luo; Hua Zhu; Tao Tan; Jianfeng He
Journal:  Front Pharmacol       Date:  2018-09-10       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.